A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma

作者:Hainsworth John D*; Arrowsmith Edward R; McCleod Michael; Hsi Eric D; Hamid Oday; Shi Peipei; Lin Boris K; Fayad Luis E
来源:Leukemia and Lymphoma, 2016, 57(1): 216-218.
DOI:10.3109/10428194.2015.1045898